- Vitamins & Supplements
- Multivitamins
- TestUdpTemporary
- Vitamins A-Z
- Mineral Supplements
- Multivitamins for Age 50+
- banner
- test 98
- Nutritional Drinks
- Adult Daily Nutrition
- Kids Nutrition (2-15 Yrs)
- For Women
- Top Deals in Supplements
- Health Food & Drinks
- Green Tea & Herbal Tea
- Herbal Juice
- Apple Cider Vinegar
- Healthy Snacks
- Protein Supplements
- Whey Protein
- Amino Acids
- Mass Gainers for testing purpose testing
- Workout Essential
- Fat Burners
Admatop 2.5 Injection
Prescription Required
Product introduction
Admatop 2.5 Injection is used in the treatment of ovarian cancer. It shows its working by stopping or slowing down the growth of cancer cells.
Admatop 2.5 Injection is used to treat various types of cancer
Admatop 2.5 Injection is used to treat various types of cancer
Uses of Admatop Injection
Benefits of Admatop Injection
In Ovarian cancer
Ovarian cancer is a cancer that begins in the female organs that produce eggs (ovaries). This type of cancer is usually detected very late and can be fatal too. It usually spreads to the pelvis and stomach. Admatop 2.5 Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective medicine but has some side effects that may be bothersome. Consult your doctor to know about ways that can help you avoid these side effects.
Side effects of Admatop Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Admatop
- Tiredness
- Vomiting
- Weakness
- Nausea
- Abdominal pain
- Indigestion
- Decreased white blood cell count
- Decreased blood cells (red cells, white cells, and platelets)
- Diarrhea
- Injection site reactions (pain, swelling, redness)
How to use Admatop Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
SAFE
Consuming alcohol with Admatop 2.5 Injection does not cause any harmful side effects.
Pregnancy
CONSULT YOUR DOCTOR
Admatop 2.5 Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
UNSAFE
Admatop 2.5 Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
UNSAFE
Admatop 2.5 Injection may cause side effects which could affect your ability to drive.
Admatop 2.5 Injection can make you feel tired and this may affect your ability to drive.
Admatop 2.5 Injection can make you feel tired and this may affect your ability to drive.
Kidney
CAUTION
Admatop 2.5 Injection should be used with caution in patients with kidney disease. Dose adjustment of Admatop 2.5 Injection may be needed. Please consult your doctor.
Use of Admatop 2.5 Injection is not recommended in patients with end-stage kidney disease.
Use of Admatop 2.5 Injection is not recommended in patients with end-stage kidney disease.
Liver
SAFE IF PRESCRIBED
Admatop 2.5 Injection is safe to use in patients with liver disease. No dose adjustment of Admatop 2.5 Injection is recommended.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Admatop 2.5 Injection helps treat ovarian cancer.
- It is given by a drip into a vein (intravenous infusion).
- Do not drive or operate machinery as Admatop 2.5 Injection may cause tiredness, drowsiness or weakness.
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine.
- Your doctor may get regular blood tests done to monitor your blood cells during treatment with this medicine.
- Inform your doctor immediately if you notice any signs of infection such as fever, sore throat, rash or severe diarrhea.
Fact Box
Chemical Class
Camptothecin Derivative
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Topoisomerase Inhibitor
Patient concerns
FAQs
How often is Admatop 2.5 Injection given?
Generally Admatop 2.5 Injection treatment is for 4 cycles of 21 day each, patient is given Admatop 2.5 Injection for first 5 days of each cycle.
Does Admatop 2.5 Injection cause hair loss?
Yes, Admatop 2.5 Injection may cause temporary hair loss.
Does Admatop 2.5 Injection cause flare reaction?
Yes, Admatop 2.5 Injection may cause flare reaction.
How long does Admatop 2.5 Injection take to work?
Admatop 2.5 Injection may start its action once the infusion is started, however, the complete effect may be assessed only after completion of 4 cycles.
Is Admatop 2.5 Injection a vesicant?
Admatop 2.5 Injection is a vesicant (irritant).
Is Admatop 2.5 Injection effective?
Yes Admatop 2.5 Injection is effective if used at prescribed doses for the prescribed duration as advised by your doctor.
What is Admatop 2.5 Injection chemotherapy?
It is a treatment therapy that includes Admatop 2.5 Injection with or without combination of other drugs in treatment of cancer (Usually ovarian or lung cancer).
How is Admatop 2.5 Injection administered?
Admatop 2.5 Injection is either administered orally as a capsule or as an intravenous Infusion in the arm over a period of 30 min.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1711-12.
- Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 951.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1383.
- Topotecan hydrochloride. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 1996 [revised 23 Apr. 2018]. [Accessed 24 Jan. 2019] (online) Available from:
- Topotecan. Unterach, Austria: Ebewe Pharma; 1996 [revised Feb. 2014]. [Accessed 27 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Topotecan. [Updated 2018 Dec 3]. [Accessed 19 Feb. 2020] (online) Available from:
Marketer details
Name: Admac Pharma Ltd
Address: SCO 84, Sector 5, Panchkula (Haryana), 134112 INDIA.
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹5299
Inclusive of all taxes
SOLD OUT
Notify me